Home » Stocks » BSTG

Biostage, Inc. (BSTG)

Stock Price: $1.25 USD 0.04 (3.31%)
Updated Jun 11, 2021 3:03 PM EDT - Market closed
Market Cap 11.74M
Revenue (ttm) n/a
Net Income (ttm) -3.74M
Shares Out 9.39M
EPS (ttm) -0.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $1.25
Previous Close $1.21
Change ($) 0.04
Change (%) 3.31%
Day's Open 1.21
Day's Range 1.21 - 1.25
Day's Volume 1,395
52-Week Range 0.80 - 3.06


Hide News

HOLLISTON, Mass., May 24, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellfra...

2 weeks ago - PRNewsWire

HOLLISTON, Mass., April 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing next-generation bioengineered esophageal implants, today a...

2 months ago - PRNewsWire

About BSTG

Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is head... [Read more...]

Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

Financial Statements